Showing results (131-140 of 292) with videos related to
Sort By:
Pageof 30
International Journal of Technology Assessment in Health Care|September 7, 2020
Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisionsLaurenz Govaerts, Anouk Waeytens, Walter Van Dyck, et al.Applied Health Economics and Health Policy|August 16, 2022
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological MedicinesYannick Vandenplas, Steven Simoens, Florian Turk, et al.Frontiers in Pharmacology|October 18, 2018
Risk-Return Analysis of the Biopharmaceutical Industry as Compared to Other IndustriesCedric Popa, Karel Holvoet, Tessa Van Montfort, et al.Pharmacoeconomics|June 30, 2017
Assessing the Value of Biosimilars: A Review of the Role of Budget Impact AnalysisSteven Simoens, Ira Jacobs, Robert Popovian, et al.International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|September 15, 2007
Implementing a hospital guideline on pneumonia: a semi-quantitative reviewPieter-Jan Cortoos, Steven Simoens, Willy Peetermans, et al.Pharmacy Practice|April 2, 2014
Detecting pre-diabetes and the role of the pharmacistSteven Simoens, Sandra De Coster, Jan Lenie, et al.Frontiers in Pharmacology|July 29, 2022
Biosimilar Use and Switching in Belgium: Avenues for Integrated PolicymakingLiese Barbier, Steven Simoens, Paul Declerck, et al.Journal of Market Access & Health Policy|April 15, 2020
Economic evaluation of biosimilars for reimbursement purposes - what, when, how?Evelien Moorkens, Hannah Broux, Isabelle Huys, et al.Targeted Oncology|November 19, 2013
Market access of cancer drugs in European countries: improving resource allocationKim Pauwels, Isabelle Huys, Minne Casteels, et al.Expert Opinion on Biological Therapy|May 26, 2025
Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergenceElif Car, Liese Barbier, Isabelle Huys, et al.Pageof 30